Vanguard Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$39.9M Buy
12,873,209
+863,436
+7% +$2.46M ﹤0.01% 2292
2025
Q3
$31.6M Buy
12,009,773
+598,981
+5% +$1.32M ﹤0.01% 2395
2025
Q2
$14M Buy
11,410,792
+1,326,911
+13% +$1.45M ﹤0.01% 2733
2025
Q1
$11.1M Buy
10,083,881
+49,732
+0.5% +$57.5K ﹤0.01% 2786
2024
Q4
$9.08M Sell
10,034,149
-1,720,248
-15% -$1.47M ﹤0.01% 3007
2024
Q3
$11.6M Sell
11,754,397
-5,854
-0% -$5.63K ﹤0.01% 2886
2024
Q2
$10.6M Sell
11,760,251
-3,533
-0% -$2.64K ﹤0.01% 2879
2024
Q1
$13.9M Buy
11,763,784
+128,150
+1% +$141K ﹤0.01% 2779
2023
Q4
$10.6M Buy
11,635,634
+367,306
+3% +$271K ﹤0.01% 2911
2023
Q3
$9.38M Buy
11,268,328
+7,686,213
+215% +$8.86M ﹤0.01% 2922
2023
Q2
$4.3M Sell
3,582,115
-2,967,636
-45% -$3.7M ﹤0.01% 3378
2023
Q1
$8.25M Sell
6,549,751
-1,410,106
-18% -$2.7M ﹤0.01% 3045
2022
Q4
$17.3M Buy
7,959,857
+613,694
+8% +$5.05M ﹤0.01% 2690
2022
Q3
$88M Buy
7,346,163
+1,493,836
+26% +$18.5M ﹤0.01% 1871
2022
Q2
$49M Buy
5,852,327
+197,585
+3% +$1.53M ﹤0.01% 2202
2022
Q1
$49.1M Buy
5,654,742
+67,283
+1% +$649K ﹤0.01% 2317
2021
Q4
$63.2M Buy
5,587,459
+88,654
+2% +$1.05M ﹤0.01% 2223
2021
Q3
$69.1M Buy
5,498,805
+65,727
+1% +$605K ﹤0.01% 2185
2021
Q2
$44.1M Buy
5,433,078
+51,327
+1% +$445K ﹤0.01% 2447
2021
Q1
$49.8M Buy
5,381,751
+23,946
+0.4% +$241K ﹤0.01% 2321
2020
Q4
$51.8M Buy
5,357,805
+647,743
+14% +$6.38M ﹤0.01% 2184
2020
Q3
$58.5M Sell
4,710,062
-172,099
-4% -$2.28M ﹤0.01% 1930
2020
Q2
$63.5M Buy
4,882,161
+1,069,894
+28% +$13.5M ﹤0.01% 1881
2020
Q1
$38.7M Buy
3,812,267
+87,199
+2% +$1.14M ﹤0.01% 1985
2019
Q4
$58.2M Sell
3,725,068
-425,915
-10% -$8.58M ﹤0.01% 2035
2019
Q3
$69.7M Buy
4,150,983
+2,523,219
+155% +$50.2M ﹤0.01% 1922
2019
Q2
$36.1M Buy
1,627,764
+255,103
+19% +$4.88M ﹤0.01% 2268
2019
Q1
$29.7M Buy
+1,372,661
New +$28.6M ﹤0.01% 2326

Other funds holding GOSS